Modernizes infant formula safety by requiring standardized pathogen and microorganism testing and mandatory notifications.
The Infant Formula Safety Modernization Act of 2026 amends the Federal Food, Drug, and Cosmetic Act to enhance safety measures for infant formula. It mandates standardized testing for pathogens and microorganisms in both manufacturing facilities and finished products. Manufacturers must notify the Secretary of positive test results within one business day. The Secretary must then notify Congress.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.